共 52 条
[1]
PREDICTORS OF SURVIVAL IN SYSTEMIC-SCLEROSIS (SCLERODERMA)
[J].
ARTHRITIS AND RHEUMATISM,
1991, 34 (04)
:403-413
[2]
PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
[J].
ARTHRITIS AND RHEUMATISM,
1980, 23 (05)
:581-590
[3]
HIGH LEVELS OF BCL-2 PROTEIN IN CIRCULATING T-LYMPHOCYTES, BUT NOT B-LYMPHOCYTES, OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
[J].
ARTHRITIS AND RHEUMATISM,
1994, 37 (10)
:1423-1430
[4]
TRIAL OF PLATELET-INHIBITING DRUG IN SCLERODERMA - DOUBLE-BLIND-STUDY WITH DIPYRIDAMOLE AND ASPIRIN
[J].
ARTHRITIS AND RHEUMATISM,
1984, 27 (10)
:1137-1143
[5]
Boudet F, 1996, J IMMUNOL, V156, P2282
[6]
Bryan C, 1996, BRIT J RHEUMATOL, V35, P1122
[7]
Conroy LA, 1996, LEUKEMIA, V10, P1422
[9]
SOLUBLE AND CELLULAR MARKERS OF IMMUNE ACTIVATION IN PATIENTS WITH SYSTEMIC-SCLEROSIS
[J].
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY,
1990, 56 (02)
:259-270
[10]
DISPALTRO FX, 1993, INT J DERMATOL, V32, P417